Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer (original) (raw)
References
Newman, B., Austin, M.A., Lee, M. & King, M-C. Inheritance of breast cancer: evidence for autosomal dominant transmission in high risk families. Proc. natn. Acad. Sci. U.S.A.85, 1–5 (1988). Article Google Scholar
Claus, E.B., Risch, N. & Thompson, W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. hum. Genet.48, 232–241 (1991). CASPubMedPubMed Central Google Scholar
Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science250, 1684–1689 (1990). ArticleCASPubMed Google Scholar
Narod, S. et al. Familial breast-ovarian cancer locus on chromosome 17q12–q23. Lancet338, 82–83 (1991). ArticleCASPubMed Google Scholar
Easton, D.F., Bishop, T., Ford, D., Crockford, G.P. & the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. hum. Genet.52, 678–701 (1993). CASPubMedPubMed Central Google Scholar
Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science265, 2088–2090 (1994). ArticleCASPubMed Google Scholar
Ford, D., Easton, D.F., Bishop, D.T., Narod, S.A. & Goldgar, D.E. Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. Lancet343, 692–695 (1994). ArticleCASPubMed Google Scholar
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science266, 66–71 (1994). ArticleCASPubMed Google Scholar
Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science266, 120–122 (1994). ArticleCASPubMed Google Scholar
Chamberlain, J.S. et al. BRCA1 Maps proximal to D17S579 on Chromosome 17q21 by genetic analysis. Am. J. hum. Genet.52, 792–798 (1993). CASPubMedPubMed Central Google Scholar
Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics5, 874–879 (1989). ArticleCASPubMed Google Scholar
Beaudet, A.L. & Tsui, L-C. A suggested nomenclature for designating mutations. Hum. Mut.2, 245–248 (1993). ArticleCASPubMed Google Scholar
Smith, S.A., Easton, D.F., Evans, D.G.R. & Ponder, B.A.J. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet.2, 128–131 (1992). ArticleCASPubMed Google Scholar
Kelsell, D.P., Black, D.M., Bishop, D.T. & Spurr, N.K. Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum. molec. Genet.2, 1823–1828 (1993). ArticleCASPubMed Google Scholar
Knudson, A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. natn. Acad. Sci. U.S.A.68, 820–823 (1971). Article Google Scholar
Levering, R. et al. Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. natn. Acad. Sci. U.S.A.90, 2112–2116 (1993). Article Google Scholar
Vidal-Puig, A. & Moller, D.E. Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methods. Bio Techniques17, 490–496 (1994). CAS Google Scholar
Duncan, B. & Miller, J. Mutagenic deamination of cytosine residues in DNA. Nature287, 560–561 (1980). ArticleCASPubMed Google Scholar
The Huntingdon Disease Collaboration Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell72, 971–983 (1993). Article Google Scholar
Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell78, 335–342 (1994). ArticleCASPubMed Google Scholar
King, M-C., Rowell, S. & Love, S.M. Inherited breast and ovarian cancer. What are the risks? What are the choices? J. Am. med. Assoc.269, 1975–1980 (1993). ArticleCAS Google Scholar
Biesecker, B.B. et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. J. Am. med. Assoc.269, 1970–1974 (1993). ArticleCAS Google Scholar
National Advisory Council for Human Genome Research. Statement on the use of DNA testing for pre-symptomatic identification of cancer risk. J. Am. med. Assoc.271, 785 (1994).
Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am. J. hum. Genet.55, i–iv (1994).
The National Breast Cancer Coalition. Presymptomatic genetic testing for heritable breast cancer risk. (1994).
Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular ctoning, a laboratory manual 2nd edn (Cold Spring Harbor Laboratory Press, New York, (1989). Google Scholar